Development of a Novel Reporter Gene Vector for Cell Based Angiogenic Studies
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
14
Page:
703-709
Author(s):
Srinivasan Kokatam, Deepshikha Pandey, Ramkrishna Gupta, Rathu Krishna and Rajeev Soni
In Vitro and In Vivo Characterization of Novel Biomaterial for Transdermal Application
Journal:
Current Drug Delivery
Volume:
8
Page:
517-525
Author(s):
Atish S. Mundada and Jasmine G. Avari
Development of Novel Combined Time and pH-Dependent based Drug Delivery Systems for Targeting 5-Fluorouracil to the Colon
Journal:
Current Drug Delivery
Volume:
8
Page:
566-574
Author(s):
M. Sidramappa Chickpetty, Raga Baswaraj and G. Sunil Kumar
Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
775-786
Author(s):
R. E. Nunez-Anita, M. Cajero-Juarez and C. Aceves
Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
826-836
Author(s):
B. B. Cheung and G. M. Marshall
Ulcerative Colitis: Pathogenesis
Journal:
Current Drug Targets
Volume:
12
Page:
1373-1382
Author(s):
Walter Fries and Salvatore Comunale
Genetics and Ulcerative Colitis: What are the Clinical Implications?
Journal:
Current Drug Targets
Volume:
12
Page:
1383-1389
Author(s):
Anna Latiano and Vito Annese
Natural History of Ulcerative Colitis: Current Knowledge
Journal:
Current Drug Targets
Volume:
12
Page:
1390-1395
Author(s):
Lajos Sandor Kiss and Peter Laszlo Lakatos
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
Journal:
Current Drug Targets
Volume:
12
Page:
1396-1405
Author(s):
Mario Cottone, Sara Renna, Irene Modesto and Ambrogio Orlando
Thiopurine Immunomodulators in Ulcerative Colitis: Moving Forward with Current Evidence
Journal:
Current Drug Targets
Volume:
12
Page:
1406-1412
Author(s):
Richard J. La Nauze and Miles P. Sparrow